Biomarker Testing for Patients With Advanced/Metastatic Nonsquamous NSCLC in the United States of America, 2015 to 2021

Biomarker Testing for Patients With Advanced/Metastatic Nonsquamous NSCLC in the United States of America, 2015 to 2021

Introduction: NSCLC is a solid tumor with a growing number of actionable biomarkers that may inform treatment. Current guidelines recommend a broad, panel-based approach be taken to identify actionable markers. This retrospective study used a deidentified electronic health records database in the Un...

Full description

Bibliographic Details
Main Authors: Lisa M. Hess, PhD, Peter M. Krein, PhD, Diane Haldane, MS, Yimei Han, MS, Anthony N. Sireci, MD
Format: Article
Language:English
Published: Elsevier 2022-06-01
Series:JTO Clinical and Research Reports
Subjects:
Biomarker testing
Non–small cell
Real-world evidence
Next-generation sequencing
Online Access:http://www.sciencedirect.com/science/article/pii/S2666364322000601

Internet

http://www.sciencedirect.com/science/article/pii/S2666364322000601

Similar Items